Evolution of the Average Target: Forvia (ex-Faurecia)

Evolution of the Average Target - Forvia (ex-Faurecia)

Evolution of the Target Price: Forvia (ex-Faurecia)

Evolution of the Target Price - Forvia (ex-Faurecia)

Changes in Analyst Recommendations: Forvia (ex-Faurecia)

fd412b6d39ee802e.72u9kwxqUFZTE48R7IeRB2LmB0gnlP6kgxxIpre9EDw.gh3KpjsGNm8AZNtIv7L2fRercnx37azxykoRlvWMfguYA_ynZiYCIRRe7A~283989c213596656472ef9a92fd162a7
04:18am Forvia: Opinion change, from Add to Reduce Alphavalue
11-02 Forvia: China gap narrows as Forvia returns to outperformance; guidance confirmed despite inflation Alphavalue
11-02 Jefferies still sees 35% upside potential for Forvia Zonebourse
11-02 French and Benelux stocks-Factors to watch on November 2 RE
10-06 Forvia catches fire, Jefferies reassured Zonebourse
09-23 AMS and Valeo lifted by brokers, Muse keeps the pressure on Orange Zonebourse
08-28 Citigroup gives auto shares' rebound another boost DP
08-03 Forvia: Solid H1 beat despite China underperformance; FY26 guidance confirmed, deleveraging on track Alphavalue
08-03 Bargain buying in Forvia, Oddo BHF stays neutral Zonebourse
07-08 Forvia holds up thanks to Citi upgrade Zonebourse
07-01 Deutsche Bank Cuts Its Target on Forvia Zonebourse
06-26 Forvia keeps sliding despite Jefferies' positive view Zonebourse
04-30 Forvia: EPS cut (2025: from € -0.46 to -7.78, 2026: from € 1.22 to 0.88) Alphavalue
04-28 Jefferies applauds divestment of Forvia's Interiors business Zonebourse
04-08 Berenberg Updates Forvia Model After Q1 Pre-close Call; Price Target Cut on Sector De-rating MT
04-07 Forvia in the red as Berenberg forecasts 24% revenue drop for Q1 Zonebourse
03-11 Forvia slips despite support from Citigroup Zonebourse
03-04 Forvia: Resilient FY25 in a Tough Environment; Ambitious 2028 Targets Unveiled at CMD Alphavalue
02-26 Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… Zonebourse
01-20 Forvia lifts EPS after Q4 pre-close Alphavalue
11-25 Forvia revises EPS outlook after non-cash charge Alphavalue
25-10-21 Forvia: UBS Maintains Neutral Rating After Q3 Revenue in Line with Expectations Zonebourse
25-10-21 Forvia: UBS still neutral after quarterly results Zonebourse
25-10-20 Forvia: Q3 results impacted by geographic mix and FX headwinds; FY25 guidance confirmed Alphavalue
25-09-12 The stock market regains its cloak of invincibility Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+54.48%
+39.43%
+7.37%
+101.48%
+79.4%
+19.8%
+13.86%
+11.42%
+7.22%
Average +37.16%
Weighted average by Cap. +37.37%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
8.906EUR
Average target price
13.64EUR
Spread / Average Target
+53.18%
High Price Target
32.00EUR
Spread / Highest target
+259.31%
Low Price Target
9.850EUR
Spread / Lowest Target
+10.60%

Analyst Consensus Detail

Analyst consensus - Forvia (ex-Faurecia)

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Forvia (ex-Faurecia)
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Forvia (ex-Faurecia)
  1. Stock Market
  2. Stocks
  3. FRVIA Stock
  4. Consensus Forvia (ex-Faurecia)